Mobile

A study to evaluate how different combinations of antiviral agents, when given with standard medicines, affect the treatment outcome of patients infected with the Hepatitis C Virus (HCV)

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-000456-42

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the antiviral efficacy as measured by sustained virologic response (SVR, defined as plasma HCV RNA < LLoQ at 24 weeks post-treatment) of response guided therapy (RGT) with GS-5885 + GS-9451 + PEG/RBV or GS-5885 + PEG/RBV.

Critère d'inclusion

  • Genotype 1 Hepatitis C Virus Infection

Liens